Moderna MRNA
NASDAQ MRNA
$145.13 +11.81 (+8.86%)
At close: Aug 21, 2026 · 4:00 PM EDT

Moderna (MRNA) Gross Margin Growth (3y) (2023 - 2026)

Moderna (MRNA) Gross Margin Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -230.00
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -168.00
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -65.00
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 14,836.00
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 589.00
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 53.00
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -3,244.00
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 569.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Roivant Sciences 26.20 Bn 26.20 Bn 1.16 Mn -21.00

Historic Data

Download Data
DateValue
Jun 30, 2026 14,836.00
Mar 31, 2026 -20,297.00
Dec 31, 2025 -5,880.00
Sep 30, 2025 1,233.00
Jun 30, 2025 -5,472.00
Mar 31, 2025 -6,657.00
Dec 31, 2024 -6,330.00
Sep 30, 2024 -1,307.00
Jun 30, 2024 -3,049.00
Mar 31, 2024 -4,752.00
Dec 31, 2023 -3,165.00
Sep 30, 2023 -12,239.00
Jun 30, 2023 -21,250.00
Mar 31, 2023 -4,253.00